PROQR THERAPEUTICS NV share price logo

PROQR THERAPEUTICS NV Share Price

NASDAQ: PRQR

Small Cap

$2.33

-0.02

(-1.06%)

as on

PROQR THERAPEUTICS NV Stock Performance

as on December 13, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $2.3
    $2.43
    downward going graph

    1.29%

    Downside

    4.29%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.07
    $3.27
    downward going graph

    54.08%

    Downside

    40.34%

    Upside

    downward going graph

PROQR THERAPEUTICS NV share price movements today

Previous Close
$2.36
Open
$2.35
Volume
1.0M
Day's Low - High
$2.3 - $2.43
52 Week Low - High
$1.07 - $3.27

PROQR THERAPEUTICS NV Historical Returns

1 Month Return
+ 7.87 %
3 Month Return
+ 6.39 %
1 Year Return
-17.67 %
3 Year Return
+ 35.47 %
5 Year Return
-45.69 %

PROQR THERAPEUTICS NV Stock Fundamentals & Key Indicators

Check PROQR THERAPEUTICS NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$248.6M

EPS (TTM)

-0.4848

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-43.6M

Revenue (TTM)

16.1M

Profit Margin

-264.83%

Return On Equity TTM

-103.76%

PROQR THERAPEUTICS NV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PROQR THERAPEUTICS NV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
PROQR THERAPEUTICS NV image
PROQR THERAPEUTICS NV
BUY$248.6M-45.69%NA-264.83%
Insmed Incorporated image
Insmed Incorporated
BUY$42.0B393.88%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$54.5B206.63%1422.861.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$114.3B101.65%31.2531.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$79.2B54.51%17.4232.13%

Stock Returns calculator for PROQR THERAPEUTICS NV Stock including INR - Dollar returns

The PROQR THERAPEUTICS NV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

PROQR THERAPEUTICS NV investment value today

Current value as on today

₹89,094

Returns

₹10,906

(-10.91%)

Returns from PROQR THERAPEUTICS NV Stock

₹17,668 (-17.67%)

Dollar Returns*

₹6,762 (+6.76%)

Analyst Recommendation on PROQR THERAPEUTICS NV Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for PROQR THERAPEUTICS NV. Average target price of $8.88

PROQR THERAPEUTICS NV Share Price Target

Get share price movements and forecasts by analysts on PROQR THERAPEUTICS NV.

What analysts predicted

73.76%UPSIDE

Target Price

$8.88

Current Price

$2.33

Analyzed by

13 Analysts

Target

$8.88

PROQR THERAPEUTICS NV target price $8.88, a slight upside of 73.76% compared to current price of $2.33. According to 13 analysts rating.

PROQR THERAPEUTICS NV Stock’s Investor Sentiment and Interest

Search interest for PROQR THERAPEUTICS NV Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

PROQR THERAPEUTICS NV Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
1
1
3
4
6
4
4
4
3
2
Gross Profit
1
1
3
4
6
4
4
4
3
2
Operating Income
-8
-7
-6
-8
-3
-8
-10
-10
-12
-11
EBITDA
-8
-6
0
-7
-2
-8
-5
-10
-11
-10
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-5
-5
-7
-2
-8
-9
-10
-12
-11
Income Tax Expense
0
0
0
0
0
-
-
-
0
-
Net Income
-8
-6
-5
-8
-2
-9
-9
-10
-12
-11
Net Profit Margin
-643.04%
-416.79%
-166.96%
-172.09%
-42.70%
-210.98%
-216.04%
-223.04%
-319.07%
-377.56%

PROQR THERAPEUTICS NV Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
10
2
-1
5
2
1
1
3
7
19
Gross Profit
9
1
-2
4
-127
1
1
3
7
19
Operating Income
-27
-39
-40
-36
-57
-42
-57
-65
-31
-30
EBITDA
-84
-120
-40
-35
-174
-48
-54
-56
-24
-24
Interest Expense
0
0
0
0
1
2
3
5
1
1
Depreciation
-
-
1
0
2
2
2
2
2
2
Income Before Tax
-20
-39
-43
-37
-56
-46
-60
-64
-27
-27
Income Tax Expense
-6
0
0
0
0
0
0
0
0
0
Net Income
-22
-41
-51
-41
-63
-56
-68
-68
-30
-29
Net Profit Margin
-221.45%
-1713.54%
2853.96%
-746.69%
-2935.64%
-4525.27%
-4549.81%
-1792.54%
-431.67%
-146.86%

PROQR THERAPEUTICS NV Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-5
-5
-7
-2
-8
-9
-10
-12
-11
Operating Cash Flow
-7
-5
-15
-6
-5
-9
-15
-11
-12
Investing Cash Flow
0
5
-17
0
16
-2
0
0
0
Financing Cash Flow
0
-1
0
0
0
71
0
0
0
Change in Cash
-8
-1
-33
-6
10
60
-16
-12
-12

PROQR THERAPEUTICS NV Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-39
-43
-37
-56
-46
-60
-64
-27
-27
Operating Cash Flow
-34
-34
-30
-43
-47
-26
-68
21
-36
Investing Cash Flow
-2
0
0
0
0
0
0
4
-4
Financing Cash Flow
0
26
88
50
14
136
-30
-2
70
Change in Cash
-35
-11
57
6
-36
111
-92
24
30

Global Institutional Holdings in PROQR THERAPEUTICS NV

Funds
Holdings
Adage Capital Partners Gp LLC
6.27%
Privium Fund Management B.V.
4.74%
Affinity Asset Advisors, LLC
3.32%
Morgan Stanley - Brokerage Accounts
2.93%
Sio Capital Management, LLC
1.97%
See all

Insights on PROQR THERAPEUTICS NV

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PRQR stock has moved up by 11.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -12.17M → -11.00M (in $), with an average increase of 10.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 885.1% return, outperforming this stock by 849.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 175.0% return, outperforming this stock by 192.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 4.51M → 2.91M (in $), with an average decrease of 19.6% per quarter

About PROQR THERAPEUTICS NV

proqr therapeutics is a leiden, nl based biotech company focused on developments of drugs to treat genetic disorders. based on a novel proprietary technology we discover and develop drugs to change the lives of patients around the world. founded by industry icons and based on ground breaking science we strive to make a meaningful impact. check out our website for vacancies: www.proqr.com
OrganisationPROQR THERAPEUTICS NV
HeadquartersZernikedreef 9, Leiden, Netherlands, 2333 CK
IndustryHealth Technology
CEOMr. Daniel Anton de Boer
E-voting on sharesClick here to vote

Key Management of PROQR THERAPEUTICS NV

Name

Title

Dr. Cristina Lopez Lopez M.D., Ph.D.

Chief Medical Officer

Ms. Sandra van der Kolk

Junior Financial Controller

Mr. Daniel Anton de Boer

Founder, CEO & Member of Management Board

Dr. Gerard Platenburg Ph.D.

Co-Founder, Chief Scientific Officer & Member of Management Board

Dr. Domenico Valerio Ph.D.

Founder & Independent Member of Supervisory Board

Mr. Dennis Hom

Chief Financial Officer

Ms. Sheila Sponselee

Chief People & Operations Officer

Ms. Sarah Cue Kiely

Vice President of Investor Relations & Corporate Communications

FAQs

What is PROQR THERAPEUTICS NV share price today?

PROQR THERAPEUTICS NV share price today is $2.33 as on at the close of the market. PROQR THERAPEUTICS NV share today touched a day high of $2.43 and a low of $2.3.

What is the 52 week high and 52 week low for PROQR THERAPEUTICS NV share?

PROQR THERAPEUTICS NV share touched a 52 week high of $3.27 on and a 52 week low of $1.07 on . PROQR THERAPEUTICS NV stock price today i.e. is closed at $2.33,which is 28.75% down from its 52 week high and 117.76% up from its 52 week low.

What is PROQR THERAPEUTICS NV's market capitalisation today?

PROQR THERAPEUTICS NV market capitalisation is $0.00T as on .

How to invest in PROQR THERAPEUTICS NV Stock (PRQR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PROQR THERAPEUTICS NV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PROQR THERAPEUTICS NV Shares that will get you 0.6438 shares as per PROQR THERAPEUTICS NV share price of $2.33 per share as on December 13, 2025 at 2:29 am IST.

What is the minimum amount required to buy PROQR THERAPEUTICS NV Stock (PRQR) from India?

Indian investors can start investing in PROQR THERAPEUTICS NV (PRQR) shares with as little as ₹90.544 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.44 in PROQR THERAPEUTICS NV stock (as per the Rupee-Dollar exchange rate as on ). Based on PROQR THERAPEUTICS NV share’s latest price of $2.33 as on December 13, 2025 at 2:29 am IST, you will get 4.2918 shares of PROQR THERAPEUTICS NV. Learn more about fractional shares .

What are the returns that PROQR THERAPEUTICS NV has given to Indian investors in the last 5 years?

PROQR THERAPEUTICS NV stock has given -45.69% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?